FEXOFENADINE HYDROCHLORIDE ORAL

FEXOFENADINE HYDROCHLORIDE ORAL was reported 6129 times

FEXOFENADINE HYDROCHLORIDE ORAL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PERSISTENT DEPRESSIVE DISORDER 12 0.0297
1 NEUROSIS 13 0.0288
2 ECZEMA HERPETICUM 9 0.0194
3 PATIENT UNCOOPERATIVE 9 0.0190
4 CHRONIC SPONTANEOUS URTICARIA 17 0.0147
5 MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED 7 0.0126
6 LEUKOPLAKIA ORAL 6 0.0117
7 VULVOVAGINAL INJURY 6 0.0105
8 CROUP INFECTIOUS 8 0.0102
9 STEROID WITHDRAWAL SYNDROME 10 0.0098
10 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 8 0.0097
11 INFUSION SITE DISCHARGE 17 0.0097
12 BASOPHIL COUNT INCREASED 7 0.0092
13 PHARYNGEAL HYPOAESTHESIA 8 0.0086
14 DEVICE MAINTENANCE ISSUE 5 0.0085
15 MICROCEPHALY 10 0.0078
16 FULMINANT TYPE 1 DIABETES MELLITUS 8 0.0078
17 QUADRIPARESIS 12 0.0072
18 IMMUNE-MEDIATED DERMATITIS 7 0.0069
19 CONVERSION DISORDER 13 0.0067
20 INTELLECTUAL DISABILITY 10 0.0066
21 INJECTION SITE BURNING 5 0.0064
22 SKIN WEEPING 21 0.0059
23 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 5 0.0057
24 NEUROPSYCHIATRIC SYMPTOMS 5 0.0055
25 INFUSION SITE IRRITATION 7 0.0054
26 INFUSION SITE BRUISING 11 0.0051
27 SEBORRHOEIC DERMATITIS 8 0.0048
28 INFECTIOUS PLEURAL EFFUSION 7 0.0046
29 HYPOPITUITARISM 8 0.0046
30 ANAEMIA POSTOPERATIVE 6 0.0046
31 PSYCHOMOTOR SKILLS IMPAIRED 12 0.0046
32 EYE ALLERGY 7 0.0045
33 ALLERGIC REACTION TO EXCIPIENT 9 0.0045
34 AGORAPHOBIA 6 0.0044
35 BONE CONTUSION 4 0.0044
36 MAST CELL ACTIVATION SYNDROME 6 0.0043
37 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 26 0.0043
38 RHINITIS ALLERGIC 19 0.0043
39 CATAPLEXY 6 0.0042
40 ADRENAL DISORDER 8 0.0042
41 INFUSION SITE WARMTH 5 0.0041
42 SENSITIVE SKIN 29 0.0039
43 RESPIRATORY TRACT INFECTION VIRAL 9 0.0039
44 INFUSION SITE PRURITUS 12 0.0038
45 HYPOPROTEINAEMIA 7 0.0037
46 SIALOADENITIS 5 0.0037
47 NASAL SEPTUM DEVIATION 7 0.0036
48 PRERENAL FAILURE 5 0.0035
49 SEASONAL ALLERGY 49 0.0035
50 INTRAMEDULLARY ROD INSERTION 7 0.0034
51 BODY TEMPERATURE ABNORMAL 6 0.0033
52 DEVICE INFUSION ISSUE 8 0.0032
53 BLOOD UREA DECREASED 4 0.0032
54 BACTERIAL VAGINOSIS 5 0.0032
55 DRUG ERUPTION 56 0.0032
56 PEMPHIGOID 23 0.0030
57 ARTHROPOD STING 5 0.0030
58 PATELLA FRACTURE 7 0.0030
59 INFUSION SITE PAIN 38 0.0029
60 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 6 0.0029
61 ENTERITIS INFECTIOUS 5 0.0029
62 MULTIPLE ALLERGIES 23 0.0029
63 ALOPECIA AREATA 5 0.0028
64 CYTOMEGALOVIRUS TEST POSITIVE 5 0.0028
65 TUMOUR HAEMORRHAGE 8 0.0028
66 ENTEROCOLITIS 16 0.0028
67 INFUSION SITE HAEMORRHAGE 9 0.0027
68 DERMATITIS CONTACT 31 0.0027
69 METASTASES TO SPINE 9 0.0027
70 THYROIDITIS 8 0.0027
71 NARCOLEPSY 5 0.0026
72 NEPHROGENIC ANAEMIA 12 0.0026
73 MENOPAUSAL SYMPTOMS 6 0.0026
74 GALLBLADDER INJURY 5 0.0026
75 VITILIGO 6 0.0026
76 PRODUCT ADMINISTRATION INTERRUPTED 20 0.0025
77 RESPIRATORY RATE DECREASED 8 0.0025
78 MYOPIA 6 0.0025
79 IMMUNE-MEDIATED ENTEROCOLITIS 9 0.0024
80 GASTROINTESTINAL MOTILITY DISORDER 13 0.0024
81 VENOUS THROMBOSIS LIMB 5 0.0024
82 HYPERTONIC BLADDER 7 0.0024
83 COLONIC POLYP 4 0.0024
84 SMALL FOR DATES BABY 12 0.0024
85 INFUSION SITE ERYTHEMA 20 0.0024
86 VULVOVAGINAL PRURITUS 12 0.0024
87 ANAEMIA MACROCYTIC 5 0.0023
88 PERIORBITAL SWELLING 13 0.0023
89 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 6 0.0023
90 CHOLANGITIS 14 0.0023
91 SKIN PAPILLOMA 9 0.0022
92 SKIN WARM 13 0.0022
93 INFUSION SITE SWELLING 14 0.0022
94 PERIARTHRITIS 5 0.0022
95 AMYLASE INCREASED 8 0.0022
96 DYSLIPIDAEMIA 11 0.0022
97 DIZZINESS POSTURAL 21 0.0022
98 TRISMUS 11 0.0021
99 HEPATIC FUNCTION ABNORMAL 79 0.0021
100 PARANASAL SINUS HYPERSECRETION 8 0.0021
101 LUMBAR SPINAL STENOSIS 6 0.0021
102 BRONCHITIS CHRONIC 5 0.0020
103 TOOTH DISCOLOURATION 6 0.0020
104 ERYTHEMA MULTIFORME 19 0.0020
105 DEPRESSION SUICIDAL 7 0.0020
106 INFUSION SITE REACTION 6 0.0020
107 HYPERKERATOSIS 11 0.0020
108 PULMONARY TOXICITY 14 0.0020
109 CANCER PAIN 5 0.0020
110 HYPERURICAEMIA 8 0.0019
111 PHYSICAL DECONDITIONING 5 0.0019
112 LIPOMA 5 0.0019
113 EYELIDS PRURITUS 6 0.0019
114 OROPHARYNGEAL DISCOMFORT 17 0.0019
115 EXPOSURE TO TOXIC AGENT 6 0.0019
116 SKIN INFECTION 21 0.0019
117 GINGIVITIS 10 0.0019
118 BRAIN FOG 29 0.0018
119 LIVER ABSCESS 6 0.0018
120 TOOTH INJURY 8 0.0018
121 BREAST ENLARGEMENT 6 0.0018
122 SPINAL CORD COMPRESSION 7 0.0018
123 INTERSTITIAL LUNG DISEASE 86 0.0018
124 ATYPICAL FEMUR FRACTURE 5 0.0018
125 LOW TURNOVER OSTEOPATHY 7 0.0018
126 SWELLING OF EYELID 11 0.0018
127 HYPERVENTILATION 10 0.0017
128 AUTONOMIC NERVOUS SYSTEM IMBALANCE 5 0.0017
129 COMPRESSION FRACTURE 9 0.0017
130 HEREDITARY ANGIOEDEMA 18 0.0017
131 ALTERED STATE OF CONSCIOUSNESS 36 0.0017
132 ADRENAL INSUFFICIENCY 20 0.0016
133 POOR VENOUS ACCESS 17 0.0016
134 ASTHMATIC CRISIS 6 0.0016
135 PHARYNGEAL SWELLING 16 0.0016
136 WRONG PRODUCT ADMINISTERED 11 0.0016
137 AUTOIMMUNE THYROIDITIS 6 0.0016
138 CATHETER SITE INFECTION 6 0.0016
139 SCHIZOPHRENIA 19 0.0016
140 EUPHORIC MOOD 16 0.0016
141 AORTIC ARTERIOSCLEROSIS 4 0.0016
142 PNEUMONIA BACTERIAL 14 0.0015
143 BLOOD CHOLESTEROL ABNORMAL 7 0.0015
144 SKIN INJURY 5 0.0015
145 INSURANCE ISSUE 23 0.0015
146 SKIN MASS 10 0.0015
147 PRODUCT SIZE ISSUE 8 0.0015
148 BRUXISM 8 0.0015
149 BASAL CELL CARCINOMA 23 0.0015
150 ANORGASMIA 4 0.0015
151 CONCOMITANT DISEASE AGGRAVATED 9 0.0015
152 UPPER-AIRWAY COUGH SYNDROME 12 0.0015
153 DIFFICULTY IN WALKING 5 0.0015
154 DERMATITIS EXFOLIATIVE GENERALISED 5 0.0014
155 FOOD ALLERGY 11 0.0014
156 INFLAMMATORY MARKER INCREASED 7 0.0014
157 INCORRECT DRUG ADMINISTRATION RATE 6 0.0014
158 FIBRIN D DIMER INCREASED 5 0.0014
159 INTERVERTEBRAL DISC DISORDER 6 0.0014
160 PNEUMONIA ASPIRATION 35 0.0014
161 HYPERAMMONAEMIA 7 0.0014
162 PRODUCT USE COMPLAINT 22 0.0014
163 MOUTH SWELLING 8 0.0014
164 TONGUE DISCOLOURATION 6 0.0014
165 PERIPHERAL SENSORY NEUROPATHY 8 0.0014
166 SPINAL OSTEOARTHRITIS 12 0.0014
167 SKIN HAEMORRHAGE 20 0.0013
168 PLEURISY 8 0.0013
169 VITAMIN D DEFICIENCY 13 0.0013
170 CHRONIC SINUSITIS 5 0.0013
171 SPINAL COMPRESSION FRACTURE 11 0.0013
172 SQUAMOUS CELL CARCINOMA OF SKIN 8 0.0013
173 VASCULAR DEVICE INFECTION 6 0.0013
174 BLOOD THYROID STIMULATING HORMONE DECREASED 6 0.0013
175 DERMATITIS ACNEIFORM 8 0.0013
176 IMMUNE THROMBOCYTOPENIA 6 0.0013
177 LUMBAR VERTEBRAL FRACTURE 6 0.0013
178 PRODUCT DISTRIBUTION ISSUE 12 0.0013
179 HYPOALBUMINAEMIA 10 0.0013
180 PELVIC FRACTURE 10 0.0013
181 NEURALGIA 31 0.0013
182 PYELONEPHRITIS 11 0.0013
183 CEREBRAL INFARCTION 31 0.0013
184 PNEUMONIA FUNGAL 5 0.0013
185 GASTRIC ULCER HAEMORRHAGE 7 0.0013
186 NASAL DISCOMFORT 10 0.0013
187 RENAL CYST 10 0.0013
188 PULMONARY ALVEOLAR HAEMORRHAGE 7 0.0012
189 RHINITIS 10 0.0012
190 UPPER RESPIRATORY TRACT INFECTION 57 0.0012
191 HYPOPHOSPHATAEMIA 9 0.0012
192 SKIN ATROPHY 7 0.0012
193 LIGAMENT SPRAIN 12 0.0012
194 ANAPHYLACTIC REACTION 67 0.0012
195 SINUS DISORDER 24 0.0012
196 NEUTROPHIL COUNT DECREASED 49 0.0012
197 SUICIDAL BEHAVIOUR 5 0.0012
198 CARDIAC FAILURE ACUTE 8 0.0012
199 EOSINOPHIL COUNT INCREASED 10 0.0012
200 ANGIOEDEMA 53 0.0012
201 BRONCHOSPASM 17 0.0012
202 SENSORY DISTURBANCE 19 0.0012
203 SINUS HEADACHE 7 0.0012
204 ESCHERICHIA URINARY TRACT INFECTION 5 0.0012
205 POOR PERIPHERAL CIRCULATION 5 0.0012
206 HYPERLIPIDAEMIA 14 0.0012
207 PULMONARY TUBERCULOSIS 5 0.0012
208 SYMPTOM RECURRENCE 7 0.0012
209 TENSION HEADACHE 5 0.0012
210 APLASIA PURE RED CELL 4 0.0012
211 LYMPHADENOPATHY 41 0.0012
212 NIGHTMARE 40 0.0012
213 LARGE INTESTINE POLYP 8 0.0012
214 DIVERTICULUM INTESTINAL 5 0.0011
215 ONYCHOMYCOSIS 5 0.0011
216 HYPERCHOLESTEROLAEMIA 11 0.0011
217 FURUNCLE 9 0.0011
218 EXTRA DOSE ADMINISTERED 46 0.0011
219 LYMPHOCYTE COUNT DECREASED 20 0.0011
220 ATRIAL FLUTTER 9 0.0011
221 EAR INFECTION 30 0.0011
222 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 19 0.0011
223 IRON DEFICIENCY 5 0.0011
224 SEXUAL DYSFUNCTION 13 0.0011
225 PANIC REACTION 8 0.0011
226 MUSCULOSKELETAL DISCOMFORT 19 0.0011
227 TIC 6 0.0011
228 ATAXIA 13 0.0011
229 CHOKING SENSATION 6 0.0011
230 SYNOVIAL CYST 5 0.0011
231 DRY THROAT 11 0.0011
232 STREPTOCOCCAL INFECTION 6 0.0011
233 DIPLOPIA 28 0.0011
234 PNEUMOTHORAX 17 0.0011
235 SNEEZING 24 0.0011
236 HYPOGAMMAGLOBULINAEMIA 7 0.0011
237 SKIN TIGHTNESS 5 0.0011
238 CHOLECYSTITIS ACUTE 6 0.0011
239 PRE-ECLAMPSIA 5 0.0011
240 PSEUDOMONAS INFECTION 9 0.0010
241 MENINGITIS 7 0.0010
242 CHOLECYSTITIS CHRONIC 7 0.0010
243 TUMOUR MARKER INCREASED 5 0.0010
244 MUSCLE STRAIN 9 0.0010
245 METASTASES TO BONE 17 0.0010
246 DERMATITIS ALLERGIC 13 0.0010
247 FEELING OF BODY TEMPERATURE CHANGE 6 0.0010
248 LIP SWELLING 34 0.0010
249 ELECTROCARDIOGRAM ABNORMAL 8 0.0010
250 COVID-19 PNEUMONIA 12 0.0010
251 BODY TEMPERATURE DECREASED 10 0.0010
252 ENCEPHALITIS 7 0.0010
253 PHOTOPHOBIA 19 0.0010
254 ORGANISING PNEUMONIA 5 0.0010
255 THIRST 18 0.0010
256 CHOLECYSTITIS 12 0.0010
257 SALIVARY HYPERSECRETION 10 0.0010
258 RESPIRATORY TRACT INFECTION 26 0.0010
259 BLEPHARITIS 4 0.0010
260 WHEEZING 59 0.0010
261 PAPULE 7 0.0010
262 DUODENAL ULCER 7 0.0010
263 MYASTHENIA GRAVIS 8 0.0010
264 TOOTH DISORDER 22 0.0010
265 DRUG-INDUCED LIVER INJURY 31 0.0010
266 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 5 0.0010
267 EYE INFECTION 11 0.0010
268 ANAPHYLACTOID REACTION 4 0.0010
269 PIGMENTATION DISORDER 6 0.0010
270 LIVER DISORDER 43 0.0010
271 SCOLIOSIS 6 0.0010
272 EYE SWELLING 36 0.0010
273 WEIGHT FLUCTUATION 10 0.0010
274 HYPOCALCAEMIA 18 0.0010
275 SPINAL DISORDER 9 0.0009
276 CYTOKINE RELEASE SYNDROME 19 0.0009
277 SINUSITIS 97 0.0009
278 FOREIGN BODY SENSATION IN EYES 6 0.0009
279 HYPOMAGNESAEMIA 13 0.0009
280 CARPAL TUNNEL SYNDROME 13 0.0009
281 BACTERAEMIA 11 0.0009
282 STRESS FRACTURE 5 0.0009
283 TENDON PAIN 7 0.0009
284 CHOKING 18 0.0009
285 PRODUCTIVE COUGH 44 0.0009
286 ORTHOSTATIC HYPOTENSION 16 0.0009
287 RESPIRATORY SYNCYTIAL VIRUS INFECTION 8 0.0009
288 ASPERGILLUS INFECTION 6 0.0009
289 URTICARIA 153 0.0009
290 DISSOCIATION 7 0.0009
291 PROCEDURAL COMPLICATION 7 0.0009
292 RHINORRHOEA 59 0.0009
293 MUSCLE TWITCHING 21 0.0009
294 HYPOKALAEMIA 42 0.0009
295 ASTHENOPIA 5 0.0009
296 INTESTINAL ISCHAEMIA 5 0.0009
297 GENERALISED TONIC-CLONIC SEIZURE 15 0.0009
298 ASTHMA 102 0.0009
299 CATHETERISATION CARDIAC 4 0.0009
300 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 7 0.0009
301 SKIN DISORDER 30 0.0009
302 FOOT FRACTURE 17 0.0009
303 PNEUMOCYSTIS JIROVECII PNEUMONIA 9 0.0009
304 FACIAL PAIN 8 0.0009
305 MYOSITIS 8 0.0009
306 ELECTROCARDIOGRAM QT PROLONGED 32 0.0009
307 POSTOPERATIVE WOUND INFECTION 6 0.0009
308 BLOOD PRESSURE DECREASED 59 0.0009
309 TASTE DISORDER 18 0.0009
310 ASCITES 26 0.0009
311 MITRAL VALVE INCOMPETENCE 10 0.0009
312 PAIN IN JAW 25 0.0009
313 RESPIRATORY TRACT CONGESTION 14 0.0009
314 BRONCHITIS 65 0.0009
315 SKIN EXFOLIATION 74 0.0009
316 ABDOMINAL HERNIA 4 0.0009
317 BUNDLE BRANCH BLOCK RIGHT 4 0.0009
318 SENSORY LOSS 7 0.0009
319 HERPES VIRUS INFECTION 5 0.0009
320 NASAL CONGESTION 51 0.0009
321 INTERVERTEBRAL DISC DEGENERATION 8 0.0009
322 ARTHRITIS INFECTIVE 4 0.0009
323 DRY EYE 43 0.0009
324 FOLLICULITIS 9 0.0009
325 STEVENS-JOHNSON SYNDROME 19 0.0009
326 DISSEMINATED INTRAVASCULAR COAGULATION 12 0.0009
327 ORAL PAIN 19 0.0008
328 CYSTITIS 27 0.0008
329 THERMAL BURN 6 0.0008
330 PHARYNGEAL OEDEMA 13 0.0008
331 DEVICE RELATED INFECTION 13 0.0008
332 COLITIS MICROSCOPIC 4 0.0008
333 CATARACT OPERATION 5 0.0008
334 SLEEP APNOEA SYNDROME 16 0.0008
335 ORAL CANDIDIASIS 11 0.0008
336 PARAESTHESIA ORAL 12 0.0008
337 FACE OEDEMA 14 0.0008
338 FEBRILE NEUTROPENIA 55 0.0008
339 HYPOKINESIA 12 0.0008
340 BLOOD LACTATE DEHYDROGENASE INCREASED 13 0.0008
341 SKIN FISSURES 16 0.0008
342 PRURITUS 313 0.0008
343 SINUS CONGESTION 11 0.0008
344 HEPATOMEGALY 8 0.0008
345 DENTAL CARIES 9 0.0008
346 FUNGAL INFECTION 27 0.0008
347 DRUG EFFECT LESS THAN EXPECTED 12 0.0008
348 GENERALISED OEDEMA 10 0.0008
349 SKIN SWELLING 7 0.0008
350 ABDOMINAL TENDERNESS 4 0.0008
351 INFUSION SITE EXTRAVASATION 5 0.0008
352 ECZEMA 42 0.0008
353 PERIPHERAL COLDNESS 11 0.0008
354 RASH MACULAR 28 0.0008
355 TUBULOINTERSTITIAL NEPHRITIS 15 0.0008
356 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 6 0.0008
357 BLOOD CREATINE PHOSPHOKINASE INCREASED 23 0.0008
358 PAROSMIA 6 0.0008
359 TOXIC SKIN ERUPTION 8 0.0008
360 HEAD DISCOMFORT 14 0.0008
361 VAGINAL DISCHARGE 8 0.0008
362 PROTEINURIA 15 0.0008
363 STAPHYLOCOCCAL INFECTION 26 0.0008
364 OXYGEN SATURATION DECREASED 44 0.0008
365 ENTERITIS 5 0.0008
366 PALPITATIONS 91 0.0008
367 THROAT TIGHTNESS 21 0.0008
368 METASTASES TO CENTRAL NERVOUS SYSTEM 10 0.0008
369 FEMUR FRACTURE 24 0.0008
370 OEDEMA 42 0.0008
371 CARDIAC FLUTTER 5 0.0008
372 TOOTHACHE 14 0.0008
373 OSTEOMYELITIS 14 0.0008
374 EAR PAIN 15 0.0008
375 HERPES SIMPLEX 5 0.0008
376 OROPHARYNGEAL PAIN 71 0.0008
377 BRADYPHRENIA 5 0.0008
378 SCAR 13 0.0008
379 IMMUNE SYSTEM DISORDER 10 0.0008
380 VERTIGO 46 0.0008
381 CELLULITIS 38 0.0008
382 GINGIVAL PAIN 6 0.0008
383 HYPOTHYROIDISM 24 0.0008
384 PLATELET COUNT DECREASED 80 0.0007
385 EPISTAXIS 56 0.0007
386 FLANK PAIN 7 0.0007
387 GASTROOESOPHAGEAL REFLUX DISEASE 60 0.0007
388 QUALITY OF LIFE DECREASED 10 0.0007
389 MENTAL IMPAIRMENT 18 0.0007
390 CHEST DISCOMFORT 75 0.0007
391 ESCHERICHIA INFECTION 6 0.0007
392 NEPHROTIC SYNDROME 5 0.0007
393 GLAUCOMA 14 0.0007
394 INFUSION RELATED REACTION 48 0.0007
395 LYMPHOEDEMA 5 0.0007
396 GASTROENTERITIS VIRAL 13 0.0007
397 DYSPNOEA EXERTIONAL 27 0.0007
398 ASPARTATE AMINOTRANSFERASE INCREASED 38 0.0007
399 RESTLESS LEGS SYNDROME 13 0.0007
400 ANGER 24 0.0007
401 HEART RATE IRREGULAR 16 0.0007
402 SWELLING FACE 46 0.0007
403 CIRCULATORY COLLAPSE 12 0.0007
404 CHOLECYSTECTOMY 8 0.0007
405 FIBROMYALGIA 17 0.0007
406 ANAPHYLACTIC SHOCK 18 0.0007
407 HERPES ZOSTER 40 0.0007
408 COVID-19 122 0.0007
409 BLOOD MAGNESIUM DECREASED 6 0.0007
410 RASH GENERALISED 18 0.0007
411 HYSTERECTOMY 6 0.0007
412 VIRAL INFECTION 23 0.0007
413 SEPTIC SHOCK 30 0.0007
414 ELECTROLYTE IMBALANCE 8 0.0007
415 FAECES SOFT 5 0.0007
416 C-REACTIVE PROTEIN INCREASED 25 0.0007
417 GASTROENTERITIS 10 0.0007
418 METASTASES TO LIVER 12 0.0007
419 DERMATITIS ATOPIC 36 0.0007
420 MOUTH HAEMORRHAGE 5 0.0007
421 COUGH 191 0.0007
422 LOSS OF CONSCIOUSNESS 87 0.0007
423 BLINDNESS TRANSIENT 5 0.0007
424 GAMMA-GLUTAMYLTRANSFERASE INCREASED 15 0.0007
425 ERYTHEMA 139 0.0007
426 STOMATITIS 41 0.0007
427 CEREBRAL DISORDER 5 0.0007
428 INSOMNIA 180 0.0007
429 ARTHROPOD BITE 5 0.0007
430 EYE PAIN 38 0.0007
431 SWOLLEN TONGUE 21 0.0007
432 PULMONARY HYPERTENSION 14 0.0007
433 TENDERNESS 7 0.0007
434 ILLNESS 69 0.0007
435 RASH ERYTHEMATOUS 32 0.0007
436 BLOOD PRESSURE SYSTOLIC INCREASED 13 0.0007
437 CHROMATURIA 15 0.0007
438 MOUTH ULCERATION 14 0.0007
439 SCRATCH 7 0.0007
440 INFLUENZA 74 0.0007
441 NECK PAIN 37 0.0007
442 MOOD SWINGS 21 0.0007
443 HEART RATE INCREASED 65 0.0007
444 RENAL IMPAIRMENT 55 0.0007
445 ACIDOSIS 5 0.0007
446 IRRITABLE BOWEL SYNDROME 14 0.0007
447 LIVER FUNCTION TEST INCREASED 14 0.0007
448 HYPERSENSITIVITY 121 0.0007
449 ALANINE AMINOTRANSFERASE INCREASED 40 0.0007
450 CANDIDA INFECTION 11 0.0007
451 POOR QUALITY SLEEP 14 0.0006
452 NERVE COMPRESSION 6 0.0006
453 IRON DEFICIENCY ANAEMIA 6 0.0006
454 SPINAL OPERATION 8 0.0006
455 SEDATION 17 0.0006
456 DECREASED ACTIVITY 7 0.0006
457 LOW DENSITY LIPOPROTEIN INCREASED 5 0.0006
458 BRONCHOPULMONARY ASPERGILLOSIS 5 0.0006
459 HEPATIC ENCEPHALOPATHY 6 0.0006
460 PNEUMONIA 208 0.0006
461 APNOEA 5 0.0006
462 ABDOMINAL DISTENSION 67 0.0006
463 VISION BLURRED 88 0.0006
464 DEVICE OCCLUSION 9 0.0006
465 HEPATIC CIRRHOSIS 12 0.0006
466 TOOTH FRACTURE 7 0.0006
467 SPUTUM DISCOLOURED 6 0.0006
468 PAIN OF SKIN 17 0.0006
469 INTENTIONAL DOSE OMISSION 18 0.0006
470 HYPERGLYCAEMIA 23 0.0006
471 RASH 275 0.0006
472 VENTRICULAR FIBRILLATION 7 0.0006
473 PYREXIA 218 0.0006
474 LACRIMATION INCREASED 19 0.0006
475 RESTLESSNESS 23 0.0006
476 EOSINOPHILIA 11 0.0006
477 PLEURAL EFFUSION 38 0.0006
478 PNEUMONITIS 17 0.0006
479 THROAT IRRITATION 28 0.0006
480 OCULAR DISCOMFORT 7 0.0006
481 UTERINE CANCER 5 0.0006
482 HAEMATURIA 21 0.0006
483 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 110 0.0006
484 JOINT INJURY 13 0.0006
485 GASTRIC HAEMORRHAGE 7 0.0006
486 SOMNOLENCE 122 0.0006
487 MYALGIA 103 0.0006
488 PHOTOSENSITIVITY REACTION 10 0.0006
489 APPETITE DISORDER 4 0.0006
490 PSYCHOMOTOR HYPERACTIVITY 10 0.0006
491 RESPIRATORY DISORDER 18 0.0006
492 CYTOMEGALOVIRUS INFECTION 10 0.0006
493 MIGRAINE 57 0.0006
494 HAEMODIALYSIS 5 0.0006
495 OSTEOPENIA 9 0.0006
496 EYELID PTOSIS 6 0.0006
497 BACTERIAL INFECTION 11 0.0006
498 TOOTH ABSCESS 6 0.0006
499 LIMB INJURY 16 0.0006
500 EPILEPSY 18 0.0006
501 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 4 0.0006
502 FEELING HOT 36 0.0006
503 ABNORMAL LOSS OF WEIGHT 4 0.0006
504 POLYNEUROPATHY 7 0.0006
505 RASH MACULO-PAPULAR 13 0.0006
506 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 6 0.0006
507 LYMPHOMA 9 0.0006
508 CENTRAL NERVOUS SYSTEM LESION 8 0.0006
509 SKIN HYPERPIGMENTATION 5 0.0006
510 TENDONITIS 9 0.0006
511 ANURIA 5 0.0006
512 HYPERBILIRUBINAEMIA 6 0.0006
513 CARDIAC MURMUR 5 0.0006
514 VENTRICULAR EXTRASYSTOLES 6 0.0006
515 DIZZINESS 288 0.0006
516 NOCTURIA 7 0.0006
517 DISTURBANCE IN ATTENTION 31 0.0006
518 HAEMOPTYSIS 16 0.0006
519 APHONIA 8 0.0006
520 DERMATITIS 12 0.0006
521 DYSURIA 21 0.0006
522 URINARY RETENTION 19 0.0006
523 GROIN PAIN 5 0.0006
524 JOINT DISLOCATION 6 0.0006
525 ABNORMAL WEIGHT GAIN 7 0.0006
526 OEDEMA PERIPHERAL 69 0.0006
527 IRRITABILITY 34 0.0006
528 ABSCESS 9 0.0006
529 GALLBLADDER DISORDER 10 0.0006
530 DECREASED APPETITE 130 0.0006
531 SYNCOPE 56 0.0006
532 SECRETION DISCHARGE 7 0.0006
533 BREAST CANCER METASTATIC 6 0.0006
534 SKIN BURNING SENSATION 40 0.0006
535 GASTROINTESTINAL INFECTION 5 0.0006
536 URINARY TRACT INFECTION 95 0.0006
537 HAEMATOCRIT DECREASED 11 0.0006
538 ATRIAL FIBRILLATION 54 0.0006
539 SLEEP DISORDER 39 0.0006
540 CONDITION AGGRAVATED 168 0.0006
541 SKIN LACERATION 6 0.0006
542 PRESCRIBED UNDERDOSE 11 0.0006
543 PANIC ATTACK 20 0.0005
544 HEADACHE 344 0.0005
545 END STAGE RENAL DISEASE 10 0.0005
546 ANXIETY 156 0.0005
547 HYPOAESTHESIA 82 0.0005
548 HYPOPHAGIA 14 0.0005
549 ARTHRITIS 43 0.0005
550 AGITATION 40 0.0005
551 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 14 0.0005
552 INCREASED TENDENCY TO BRUISE 5 0.0005
553 EXPIRED PRODUCT ADMINISTERED 18 0.0005
554 AGRANULOCYTOSIS 10 0.0005
555 IMMUNODEFICIENCY 8 0.0005
556 EYE PRURITUS 18 0.0005
557 HYPERHIDROSIS 69 0.0005
558 APPENDICITIS 5 0.0005
559 DYSARTHRIA 20 0.0005
560 BREAST TENDERNESS 4 0.0005
561 DIARRHOEA 342 0.0005
562 MALIGNANT NEOPLASM PROGRESSION 54 0.0005
563 WHITE BLOOD CELL COUNT DECREASED 57 0.0005
564 AORTIC ANEURYSM 4 0.0005
565 DISEASE RECURRENCE 25 0.0005
566 INFLAMMATION 27 0.0005
567 CONSTIPATION 114 0.0005
568 LOWER LIMB FRACTURE 10 0.0005
569 ACCIDENTAL OVERDOSE 19 0.0005
570 METASTASES TO LUNG 6 0.0005
571 MUSCULAR WEAKNESS 59 0.0005
572 ATRIOVENTRICULAR BLOCK 4 0.0005
573 EYE DISORDER 17 0.0005
574 PRESCRIBED OVERDOSE 10 0.0005
575 BACK PAIN 120 0.0005
576 EYELID OEDEMA 6 0.0005
577 HYPERKALAEMIA 18 0.0005
578 DYSPHONIA 30 0.0005
579 HAEMORRHOIDS 10 0.0005
580 ORAL HERPES 10 0.0005
581 OSTEOPOROSIS 21 0.0005
582 DEHYDRATION 68 0.0005
583 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
584 CONTUSION 49 0.0005
585 DEEP VEIN THROMBOSIS 33 0.0005
586 FAECES DISCOLOURED 11 0.0005
587 TREMOR 84 0.0005
588 DRY MOUTH 41 0.0005
589 PRODUCT PRESCRIBING ISSUE 11 0.0005
590 CATARACT 30 0.0005
591 MEDICATION ERROR 28 0.0005
592 RHABDOMYOLYSIS 21 0.0005
593 POLLAKIURIA 21 0.0005
594 BLADDER DISORDER 5 0.0005
595 MACULAR DEGENERATION 6 0.0005
596 WRIST FRACTURE 6 0.0005
597 SPINAL FRACTURE 10 0.0005
598 CARDIAC FAILURE 40 0.0005
599 DYSPNOEA 282 0.0005
600 HYPONATRAEMIA 28 0.0005
601 FULL BLOOD COUNT DECREASED 10 0.0005
602 PRODUCT ADMINISTRATION ERROR 10 0.0005
603 SURGERY 29 0.0005
604 PRESYNCOPE 12 0.0005
605 INJECTION SITE PRURITUS 33 0.0005
606 COGNITIVE DISORDER 23 0.0005
607 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 35 0.0005
608 BRADYCARDIA 26 0.0005
609 ASPHYXIA 4 0.0005
610 RED BLOOD CELL COUNT DECREASED 14 0.0005
611 RESPIRATORY DEPRESSION 6 0.0005
612 PARAESTHESIA 77 0.0005
613 SUBDURAL HAEMATOMA 7 0.0005
614 INJECTION SITE RASH 15 0.0005
615 HYPERSOMNIA 14 0.0005
616 NASOPHARYNGITIS 90 0.0005
617 INITIAL INSOMNIA 5 0.0005
618 BLOOD GLUCOSE ABNORMAL 9 0.0005
619 CHRONIC KIDNEY DISEASE 37 0.0005
620 LETHARGY 28 0.0005
621 TENDON RUPTURE 6 0.0005
622 PHARYNGITIS 6 0.0005
623 HEPATIC STEATOSIS 9 0.0005
624 TOOTH EXTRACTION 6 0.0005
625 ABDOMINAL PAIN UPPER 99 0.0005
626 APATHY 7 0.0005
627 TINNITUS 22 0.0005
628 ACUTE KIDNEY INJURY 73 0.0005
629 INFECTION 69 0.0005
630 FEELING ABNORMAL 114 0.0005
631 FRACTURE 9 0.0005
632 KNEE ARTHROPLASTY 10 0.0005
633 CARDIOMYOPATHY 7 0.0005
634 NEUROPATHY PERIPHERAL 45 0.0005
635 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 11 0.0005
636 INJECTION SITE IRRITATION 6 0.0005
637 INCREASED APPETITE 9 0.0005
638 COLON CANCER 7 0.0005
639 WHITE BLOOD CELL COUNT INCREASED 18 0.0005
640 BODY HEIGHT DECREASED 5 0.0005
641 PERIPHERAL SWELLING 72 0.0005
642 ANAEMIA 89 0.0005
643 NIGHT SWEATS 15 0.0005
644 MALAISE 204 0.0005
645 ARRHYTHMIA 22 0.0005
646 HEPATIC FAILURE 14 0.0005
647 INJECTION SITE INDURATION 6 0.0005
648 PRURITUS GENERALISED 10 0.0005
649 DEVICE FAILURE 7 0.0005
650 HYPERTENSION 97 0.0005
651 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
652 CHOLELITHIASIS 15 0.0005
653 HIP ARTHROPLASTY 7 0.0005
654 WOUND INFECTION 5 0.0005
655 INJECTION SITE NODULE 5 0.0005
656 DEPRESSED MOOD 24 0.0005
657 CHEST PAIN 84 0.0005
658 WITHDRAWAL SYNDROME 19 0.0005
659 LIMB DISCOMFORT 14 0.0005
660 BLOOD PRESSURE INCREASED 69 0.0005
661 HALLUCINATION 34 0.0005
662 RENAL DISORDER 21 0.0005
663 BLOOD CHOLESTEROL INCREASED 21 0.0005
664 NERVE INJURY 5 0.0004
665 INTESTINAL PERFORATION 5 0.0004
666 NEPHROPATHY TOXIC 5 0.0004
667 THERAPEUTIC RESPONSE DECREASED 27 0.0004
668 MUSCULOSKELETAL STIFFNESS 39 0.0004
669 PANCREATITIS ACUTE 10 0.0004
670 OSTEONECROSIS OF JAW 11 0.0004
671 BLOOD BILIRUBIN INCREASED 12 0.0004
672 RASH PRURITIC 24 0.0004
673 HEAD INJURY 14 0.0004
674 TACHYPNOEA 6 0.0004
675 NAUSEA 348 0.0004
676 PRODUCT DOSE OMISSION ISSUE 129 0.0004
677 INJECTION SITE WARMTH 9 0.0004
678 CARDIAC FAILURE CONGESTIVE 35 0.0004
679 SKIN DISCOLOURATION 20 0.0004
680 CHILLS 51 0.0004
681 PERITONITIS 9 0.0004
682 DRY SKIN 58 0.0004
683 WEIGHT INCREASED 97 0.0004
684 MUSCLE TIGHTNESS 7 0.0004
685 DYSPHAGIA 41 0.0004
686 CONJUNCTIVITIS 8 0.0004
687 FEELING COLD 12 0.0004
688 DYSGEUSIA 32 0.0004
689 DEPRESSION 98 0.0004
690 DEPRESSED LEVEL OF CONSCIOUSNESS 17 0.0004
691 CAESAREAN SECTION 5 0.0004
692 BLOOD CREATININE INCREASED 28 0.0004
693 MIDDLE INSOMNIA 8 0.0004
694 HEART RATE DECREASED 15 0.0004
695 HYPOXIA 15 0.0004
696 SKIN ULCER 11 0.0004
697 HOT FLUSH 32 0.0004
698 OSTEOARTHRITIS 18 0.0004
699 INTESTINAL OBSTRUCTION 16 0.0004
700 BLOOD SODIUM DECREASED 8 0.0004
701 VENTRICULAR TACHYCARDIA 7 0.0004
702 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
703 THERAPY NON-RESPONDER 19 0.0004
704 INTENTIONAL PRODUCT USE ISSUE 37 0.0004
705 NEUROLEPTIC MALIGNANT SYNDROME 5 0.0004
706 BLOOD IRON DECREASED 5 0.0004
707 DEAFNESS 11 0.0004
708 FALL 140 0.0004
709 COAGULOPATHY 7 0.0004
710 SPEECH DISORDER 22 0.0004
711 PRODUCT USE IN UNAPPROVED INDICATION 104 0.0004
712 MYOCLONUS 5 0.0004
713 PARALYSIS 6 0.0004
714 CEREBRAL HAEMORRHAGE 15 0.0004
715 ANHEDONIA 11 0.0004
716 GASTRITIS 11 0.0004
717 IMPAIRED QUALITY OF LIFE 6 0.0004
718 POST PROCEDURAL COMPLICATION 8 0.0004
719 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 20 0.0004
720 DIABETIC KETOACIDOSIS 10 0.0004
721 ACUTE RESPIRATORY FAILURE 8 0.0004
722 FATIGUE 323 0.0004
723 MYELODYSPLASTIC SYNDROME 6 0.0004
724 ANOSMIA 6 0.0004
725 MUSCLE SPASMS 76 0.0004
726 COMPLICATION ASSOCIATED WITH DEVICE 6 0.0004
727 FLUID RETENTION 21 0.0004
728 AUTOIMMUNE DISORDER 4 0.0004
729 DISCOMFORT 25 0.0004
730 WEIGHT DECREASED 114 0.0004
731 KIDNEY INFECTION 8 0.0004
732 ACUTE MYOCARDIAL INFARCTION 12 0.0004
733 SEIZURE 47 0.0004
734 DYSPEPSIA 40 0.0004
735 BALANCE DISORDER 35 0.0004
736 INJECTION SITE SWELLING 31 0.0004
737 CYST 5 0.0004
738 OCULAR HYPERAEMIA 19 0.0004
739 PULMONARY EMBOLISM 38 0.0004
740 INJURY 28 0.0004
741 HYPOAESTHESIA ORAL 6 0.0004
742 RESPIRATORY FAILURE 29 0.0004
743 COLD SWEAT 7 0.0004
744 PAIN IN EXTREMITY 117 0.0004
745 DIVERTICULITIS 11 0.0004
746 ARTHRALGIA 165 0.0004
747 DIABETES MELLITUS 30 0.0004
748 VOMITING 185 0.0004
749 BLISTER 22 0.0004
750 ERECTILE DYSFUNCTION 10 0.0004
751 ROTATOR CUFF SYNDROME 5 0.0004
752 PERICARDIAL EFFUSION 9 0.0004
753 MUSCULOSKELETAL CHEST PAIN 6 0.0004
754 HIATUS HERNIA 5 0.0004
755 ANGINA PECTORIS 11 0.0004
756 PLATELET COUNT INCREASED 5 0.0004
757 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 20 0.0004
758 NERVOUSNESS 20 0.0004
759 ABDOMINAL DISCOMFORT 64 0.0004
760 THERAPEUTIC PRODUCT EFFECT DECREASED 17 0.0004
761 GASTROINTESTINAL DISORDER 34 0.0004
762 TOOTH INFECTION 5 0.0004
763 HALLUCINATION, VISUAL 8 0.0004
764 DISORIENTATION 15 0.0004
765 ABDOMINAL PAIN 88 0.0004
766 NEEDLE ISSUE 11 0.0004
767 SEPSIS 42 0.0004
768 DELIRIUM 13 0.0004
769 FLUSHING 38 0.0004
770 SKIN IRRITATION 17 0.0004
771 NEPHROLITHIASIS 17 0.0004
772 COLITIS 14 0.0004
773 BACK DISORDER 6 0.0004
774 LUNG DISORDER 18 0.0004
775 INJECTION SITE URTICARIA 9 0.0004
776 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
777 EYE IRRITATION 21 0.0004
778 MANIA 6 0.0004
779 SWELLING 34 0.0004
780 THERAPEUTIC RESPONSE SHORTENED 12 0.0004
781 MYELOSUPPRESSION 13 0.0004
782 DYSTONIA 7 0.0004
783 AGEUSIA 9 0.0004
784 TACHYCARDIA 32 0.0004
785 ORAL DISCOMFORT 5 0.0004
786 DRUG INTERACTION 57 0.0004
787 CONFUSIONAL STATE 58 0.0004
788 WOUND 10 0.0004
789 GLOSSODYNIA 8 0.0004
790 PULMONARY OEDEMA 16 0.0004
791 ABDOMINAL PAIN LOWER 9 0.0004
792 INJECTION SITE ERYTHEMA 44 0.0004
793 FLATULENCE 20 0.0004
794 INFLUENZA LIKE ILLNESS 29 0.0004
795 LOWER RESPIRATORY TRACT INFECTION 16 0.0004
796 PAIN 216 0.0004
797 CARDIOGENIC SHOCK 5 0.0003
798 THROMBOSIS 28 0.0003
799 EXPOSURE VIA SKIN CONTACT 9 0.0003
800 VISUAL IMPAIRMENT 43 0.0003
801 FEEDING DISORDER 7 0.0003
802 LOCAL SWELLING 6 0.0003
803 RIB FRACTURE 7 0.0003
804 AMNESIA 22 0.0003
805 DRUG INEFFECTIVE 443 0.0003
806 PULMONARY MASS 5 0.0003
807 PRODUCT USE ISSUE 63 0.0003
808 JAUNDICE 9 0.0003
809 BLOOD PRESSURE FLUCTUATION 8 0.0003
810 BLOOD POTASSIUM DECREASED 10 0.0003
811 CORONARY ARTERY DISEASE 10 0.0003
812 BURSITIS 4 0.0003
813 TOXIC EPIDERMAL NECROLYSIS 5 0.0003
814 RETCHING 7 0.0003
815 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 18 0.0003
816 BURNING SENSATION 23 0.0003
817 TRANSIENT ISCHAEMIC ATTACK 11 0.0003
818 CARDIOMEGALY 4 0.0003
819 THYROID DISORDER 5 0.0003
820 BONE PAIN 19 0.0003
821 ANKLE FRACTURE 5 0.0003
822 BLOOD ALKALINE PHOSPHATASE INCREASED 8 0.0003
823 PANCYTOPENIA 18 0.0003
824 THINKING ABNORMAL 6 0.0003
825 DELUSION 5 0.0003
826 ACUTE MYELOID LEUKAEMIA 5 0.0003
827 HYPOTENSION 64 0.0003
828 MELAENA 7 0.0003
829 CYANOSIS 5 0.0003
830 BRAIN OEDEMA 4 0.0003
831 BLOOD URINE PRESENT 6 0.0003
832 FEELING JITTERY 6 0.0003
833 THERAPEUTIC RESPONSE UNEXPECTED 14 0.0003
834 ASTHENIA 117 0.0003
835 INCORRECT DOSE ADMINISTERED 71 0.0003
836 ALOPECIA 61 0.0003
837 ANOREXIA 4 0.0003
838 HERNIA 6 0.0003
839 ERUCTATION 6 0.0003
840 SYSTEMIC LUPUS ERYTHEMATOSUS 11 0.0003
841 HYPOGLYCAEMIA 15 0.0003
842 PRODUCT QUALITY ISSUE 42 0.0003
843 DYSSTASIA 9 0.0003
844 HAEMATOCHEZIA 17 0.0003
845 BLOOD POTASSIUM INCREASED 5 0.0003
846 THERAPY INTERRUPTED 22 0.0003
847 PLASMA CELL MYELOMA 12 0.0003
848 ARTHROPATHY 17 0.0003
849 MEMORY IMPAIRMENT 42 0.0003
850 JOINT STIFFNESS 8 0.0003
851 UNEVALUABLE EVENT 23 0.0003
852 BLOOD UREA INCREASED 5 0.0003
853 INJECTION SITE PAIN 91 0.0003
854 DYSKINESIA 12 0.0003
855 HEMIPARESIS 5 0.0003
856 SUICIDAL IDEATION 27 0.0003
857 RENAL FAILURE 39 0.0003
858 UNDERDOSE 21 0.0003
859 CARDIO-RESPIRATORY ARREST 12 0.0003
860 MUSCULOSKELETAL PAIN 15 0.0003
861 PANCREATITIS 15 0.0003
862 FOETAL EXPOSURE DURING PREGNANCY 23 0.0003
863 RENAL FAILURE ACUTE 12 0.0003
864 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
865 METABOLIC ACIDOSIS 9 0.0003
866 MOVEMENT DISORDER 9 0.0003
867 SKIN CANCER 6 0.0003
868 GOUT 5 0.0003
869 CARDIAC ARREST 23 0.0003
870 ABNORMAL BEHAVIOUR 11 0.0003
871 HAEMATEMESIS 7 0.0003
872 INJECTION SITE BRUISING 22 0.0003
873 HEPATITIS 7 0.0003
874 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 8 0.0003
875 DRUG RESISTANCE 7 0.0003
876 URINARY INCONTINENCE 8 0.0003
877 RASH PAPULAR 6 0.0003
878 MUCOSAL INFLAMMATION 7 0.0003
879 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 54 0.0003
880 JOINT SWELLING 32 0.0003
881 HEPATIC ENZYME INCREASED 18 0.0003
882 SUICIDE ATTEMPT 16 0.0003
883 CONVULSION 15 0.0003
884 PALLOR 7 0.0003
885 RHEUMATOID ARTHRITIS 29 0.0003
886 SKIN LESION 7 0.0003
887 RESPIRATORY DISTRESS 7 0.0003
888 DISABILITY 5 0.0003
889 MENTAL DISORDER 11 0.0003
890 PROCEDURAL PAIN 7 0.0003
891 GENERAL PHYSICAL HEALTH DETERIORATION 29 0.0003
892 ACNE 19 0.0003
893 DEMENTIA 7 0.0003
894 INJECTION SITE HAEMORRHAGE 20 0.0003
895 OFF LABEL USE 219 0.0002
896 BLOOD GLUCOSE DECREASED 12 0.0002
897 HIP FRACTURE 8 0.0002
898 DRUG INTOLERANCE 24 0.0002
899 PRODUCT PHYSICAL ISSUE 5 0.0002
900 EMOTIONAL DISTRESS 30 0.0002
901 BONE MARROW FAILURE 5 0.0002
902 ADVERSE DRUG REACTION 22 0.0002
903 EXTRAPYRAMIDAL DISORDER 6 0.0002
904 THROMBOCYTOPENIA 27 0.0002
905 VISUAL ACUITY REDUCED 8 0.0002
906 LIVER FUNCTION TEST ABNORMAL 7 0.0002
907 GASTROINTESTINAL HAEMORRHAGE 20 0.0002
908 GASTRIC CANCER 6 0.0002
909 NEUTROPENIA 32 0.0002
910 GAIT DISTURBANCE 45 0.0002
911 EATING DISORDER 5 0.0002
912 IMPAIRED WORK ABILITY 5 0.0002
913 THERAPY CESSATION 12 0.0002
914 INJECTION SITE REACTION 16 0.0002
915 APHASIA 7 0.0002
916 DISEASE PROGRESSION 27 0.0002
917 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
918 BLINDNESS 9 0.0002
919 MOOD ALTERED 6 0.0002
920 LEUKOPENIA 11 0.0002
921 BONE DISORDER 4 0.0002
922 INTENTIONAL OVERDOSE 14 0.0002
923 IMPAIRED HEALING 7 0.0002
924 MATERNAL EXPOSURE DURING PREGNANCY 19 0.0002
925 OSTEONECROSIS 7 0.0002
926 PRODUCT PRESCRIBING ERROR 5 0.0002
927 RECTAL HAEMORRHAGE 9 0.0002
928 DRUG EXPOSURE DURING PREGNANCY 7 0.0002
929 HAEMOGLOBIN DECREASED 21 0.0002
930 LABORATORY TEST ABNORMAL 6 0.0002
931 RENAL INJURY 6 0.0002
932 BLOOD PRESSURE ABNORMAL 4 0.0002
933 TREATMENT NONCOMPLIANCE 11 0.0002
934 HAEMORRHAGE 21 0.0002
935 ABORTION SPONTANEOUS 8 0.0002
936 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
937 ILL-DEFINED DISORDER 12 0.0002
938 BODY TEMPERATURE INCREASED 4 0.0002
939 MYOCARDIAL INFARCTION 34 0.0002
940 MOBILITY DECREASED 14 0.0002
941 CRYING 7 0.0002
942 NERVOUS SYSTEM DISORDER 6 0.0002
943 ROAD TRAFFIC ACCIDENT 8 0.0002
944 PRODUCT SUBSTITUTION ISSUE 11 0.0002
945 DEVICE ISSUE 17 0.0002
946 MENSTRUATION IRREGULAR 5 0.0002
947 LACTIC ACIDOSIS 6 0.0002
948 FREQUENT BOWEL MOVEMENTS 5 0.0002
949 VAGINAL HAEMORRHAGE 8 0.0002
950 DEVICE DELIVERY SYSTEM ISSUE 5 0.0002
951 ABNORMAL DREAMS 5 0.0002
952 AGGRESSION 9 0.0002
953 NEOPLASM MALIGNANT 12 0.0002
954 GAIT INABILITY 6 0.0002
955 TYPE 2 DIABETES MELLITUS 6 0.0002
956 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
957 EXPOSURE DURING PREGNANCY 11 0.0002
958 ADVERSE EVENT 16 0.0002
959 NEOPLASM PROGRESSION 6 0.0002
960 LUNG NEOPLASM MALIGNANT 7 0.0002
961 HOSPITALISATION 26 0.0002
962 PREMATURE BABY 5 0.0002
963 DRUG EFFECT INCOMPLETE 6 0.0002
964 HYPOACUSIS 7 0.0002
965 INJECTION SITE MASS 6 0.0002
966 CARDIAC DISORDER 15 0.0002
967 INTENTIONAL PRODUCT MISUSE 14 0.0002
968 COMPLETED SUICIDE 13 0.0002
969 NO ADVERSE EVENT 28 0.0002
970 TOXICITY TO VARIOUS AGENTS 26 0.0002
971 BREAST CANCER 14 0.0002
972 OVERDOSE 32 0.0001
973 CEREBROVASCULAR ACCIDENT 25 0.0001
974 MULTIPLE SCLEROSIS 7 0.0001
975 DEVICE DISLOCATION 6 0.0001
976 DRUG EFFECT DECREASED 7 0.0001
977 DEVICE BREAKAGE 5 0.0001
978 PSORIASIS 16 0.0001
979 DEVICE LEAKAGE 5 0.0001
980 TREATMENT FAILURE 9 0.0001
981 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
982 DRUG WITHDRAWAL SYNDROME 9 0.0001
983 MULTIPLE SCLEROSIS RELAPSE 7 0.0001
984 BLOOD GLUCOSE INCREASED 19 0.0001
985 DEVICE DIFFICULT TO USE 6 0.0001
986 DRUG DEPENDENCE 14 0.0001
987 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
988 PRODUCT STORAGE ERROR 7 0.0001
989 PRODUCT DOSE OMISSION 5 0.0001
990 DEVICE MALFUNCTION 5 0.0001
991 DRUG DOSE OMISSION 11 0.0001
992 DEATH 56 0.0001